Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 94

    ENDS devices inlcuding e-Cigarettes, E-Sheesha classified as DRUGS, under DCA, Holds CDSCO DTAB

    ENDS devices inlcuding e-Cigarettes, E-Sheesha classified as DRUGS, under DCA, Holds CDSCO DTAB

    Medical Dialogues Bureau6 Sept 2019 5:16 PM IST
    New Delhi: Clearly stating that E-Sheesha, E-Nicotine, Flavoured Hookah and the like devices are recognized as "Drugs" under Section 26A of the Drugs...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    SEBI directs Sun Pharma to undergo forensic audit of financial statements for FY16-18

    SEBI directs Sun Pharma to undergo forensic audit of financial statements for FY16-18

    Medical Dialogues Bureau6 Sept 2019 9:50 AM IST
    Sun Pharma, however, did not provide any specific details on the reasons for the Securities and Exchange Board of India to order the forensic...
    Unichem Labs successfully completes USFDA inspection of Pithampur facility

    Unichem Labs successfully completes USFDA inspection of Pithampur facility

    Medical Dialogues Bureau6 Sept 2019 9:45 AM IST
    "The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Pithampur, Active Pharmaceutical Ingredients (APIs)...
    Landmark Trial for Dapagliflozin: AstraZeneca diabetes drug Forxiga shows benefits in patients with heart failure

    Landmark Trial for Dapagliflozin: AstraZeneca diabetes drug Forxiga shows benefits in patients with heart failure

    Farhat Nasim6 Sept 2019 9:17 AM IST
    Dapagliflozin(Forxiga) is currently available and indicated for type 2 diabetes in India and not yet approved for treatment for heart failure in...
    Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

    Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

    Medical Dialogues Bureau6 Sept 2019 9:00 AM IST
    "Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
    Payment of fees in Bharatkosh through Sugam portal: CDSCO issues notice

    Payment of fees in Bharatkosh through Sugam portal: CDSCO issues notice

    Farhat Nasim5 Sept 2019 5:26 PM IST
    In order to facilitate the payment of fees by the stakeholders, it has been decided by the Directorate that once the fees are debited from the account...
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sept 2019 5:01 PM IST
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha

    Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha

    Medical Dialogues Bureau5 Sept 2019 9:45 AM IST
    In his message to the company's shareholders, Glenmark Pharma Chairman and MD Glenn Saldanha said the three entities will focus on different verticals...
    AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer

    AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer

    Medical Dialogues Bureau5 Sept 2019 9:30 AM IST
    China approved Tagrisso as a first-line treatment for adults with non-small cell lung cancer patients whose tumours have certain genetic mutations,...
    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Medical Dialogues Bureau5 Sept 2019 9:15 AM IST
    ZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
    Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

    Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

    Medical Dialogues Bureau5 Sept 2019 9:00 AM IST
    Bilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok